On December 4, 2024, Breighner Robert G. JR, Vice President, Compliance at Select Medical Holdings Corp, executed a sale of 4,989 shares of the company. Following this transaction, the insider now holds 30,356 shares of Select Medical Holdings Corp. The details of this transaction can be found in the SEC Filing.
Select Medical Holdings Corp (SEM, Financial) is a healthcare company that operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers. The company provides specialized healthcare services in both inpatient and outpatient settings.
The insider transaction history for Select Medical Holdings Corp indicates that there have been no insider buys over the past year, while there have been eight insider sells during the same period. Over the past year, Breighner Robert G. JR has sold a total of 4,989 shares and has not purchased any shares.
On the day of the recent sale, shares of Select Medical Holdings Corp were trading at $19.95 each, giving the stock a market cap of $2.556 billion. The company's price-earnings ratio stands at 9.26, which is lower than the industry median of 22.85 but higher than the company’s historical median price-earnings ratio.
With a trading price of $19.95 and a GF Value of $30.08, Select Medical Holdings Corp has a price-to-GF-Value ratio of 0.66. This suggests that the stock is considered a "Possible Value Trap, Think Twice" based on its GF Value.
The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on three factors:
- Historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow that the stock has traded at.
- A GuruFocus adjustment factor based on the company’s past returns and growth.
- Future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
